Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol
- 1 June 2004
- journal article
- Published by Wiley in Respirology
- Vol. 9 (2) , 173-183
- https://doi.org/10.1111/j.1440-1843.2004.00588.x
Abstract
Objective: There is so far no consensus on the optimal treatment strategy for the coronavirus‐associated severe acute respiratory syndrome (SARS). We aimed to analyse the outcomes of a standard treatment strategy comprising antibiotics, a combination of ribavirin, a 3‐week step‐down course of corticosteroids, and the possibility of pulsed methylprednisolone rescue in the event of deterioration.Keywords
This publication has 33 references indexed in Scilit:
- Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome MortalityEmerging Infectious Diseases, 2003
- Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic CorrelatesEmerging Infectious Diseases, 2003
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003
- Rapid Diagnosis of a Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS)Clinical Chemistry, 2003
- A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- A Major Outbreak of Severe Acute Respiratory Syndrome in Hong KongNew England Journal of Medicine, 2003
- A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong KongNew England Journal of Medicine, 2003
- Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cellsThe FASEB Journal, 2002
- A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurementComputers in Biology and Medicine, 1990